Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Seminars in Oncology
|
September 1, 1986
Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma
P Bonomi, K Rowland, S G Taylor, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 26, 2006
Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling
M R Shiran, N J Proctor, E M Howgate, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 27, 2006
Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences
S Inoue, E M Howgate, K Rowland-Yeo, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
February 20, 1999
Laparoscopic gastrostomy and jejunostomy: safety and cost with local vs general anesthesia
Q Y Duh, A L Senokozlieff-Englehart, Y S Choe, et al.
Journal of the Pediatric Orthopaedic Society of North America
|
January 26, 2026
Determination of At-Risk Pediatric Population in Orthopaedic Fracture Clinic Using Pediatric Adverse Childhood Experiences and Related Life Events Screener
Katherine Snipes, Hadley C Hutchison, Jeff Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2013
N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial
W W Tan, A C Dueck, P Flynn, et al.
BMJ (Clinical Research Ed.)
|
March 11, 2000
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population
E J Wallis, L E Ramsay, I Ul Haq, et al.
American Journal of Obstetrics and Gynecology
|
October 22, 2008
South Carolina Partners for Preterm Birth Prevention: a regional perinatal initiative for the reduction of premature birth in a Medicaid population
Roger B Newman, Scott A Sullivan, M Kathryn Menard, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 2, 2013
Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine
A S Darwich, D Pade, K Rowland-Yeo, et al.
Current Drug Metabolism
|
April 14, 2006
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation
F Ghanbari, K Rowland-Yeo, J C Bloomer, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Seminars in Oncology
|
September 1, 1986
Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma
P Bonomi, K Rowland, S G Taylor, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 26, 2006
Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling
M R Shiran, N J Proctor, E M Howgate, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 27, 2006
Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences
S Inoue, E M Howgate, K Rowland-Yeo, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
February 20, 1999
Laparoscopic gastrostomy and jejunostomy: safety and cost with local vs general anesthesia
Q Y Duh, A L Senokozlieff-Englehart, Y S Choe, et al.
Journal of the Pediatric Orthopaedic Society of North America
|
January 26, 2026
Determination of At-Risk Pediatric Population in Orthopaedic Fracture Clinic Using Pediatric Adverse Childhood Experiences and Related Life Events Screener
Katherine Snipes, Hadley C Hutchison, Jeff Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2013
N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial
W W Tan, A C Dueck, P Flynn, et al.
BMJ (Clinical Research Ed.)
|
March 11, 2000
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population
E J Wallis, L E Ramsay, I Ul Haq, et al.
American Journal of Obstetrics and Gynecology
|
October 22, 2008
South Carolina Partners for Preterm Birth Prevention: a regional perinatal initiative for the reduction of premature birth in a Medicaid population
Roger B Newman, Scott A Sullivan, M Kathryn Menard, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 2, 2013
Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine
A S Darwich, D Pade, K Rowland-Yeo, et al.
Current Drug Metabolism
|
April 14, 2006
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation
F Ghanbari, K Rowland-Yeo, J C Bloomer, et al.
Page
of 7